{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:10:25Z","timestamp":1788952225819,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Among the various long-term iatrogenic sequelae associated with the treatment of pediatric and adolescent patients with malignancies, secondary malignant neoplasms (SMNs) are among the greatest concerns. Chemotherapeutic agents may increase the risk of SMNs. We present the first case of a patient initially diagnosed with T-cell acute lymphoblastic leukemia (T-ALL), who received 30 months of chemotherapy, including the alkylating agent cyclophosphamide, the topoisomerase II inhibitor daunorubicin, and subsequently developed cervical anaplastic large cell lymphoma (ALCL) three years after the initial diagnosis. We also present the second case of a patient initially diagnosed with clear cell sarcoma of the kidney (CCSK), who underwent 6 months of chemotherapy, including the alkylating agent cyclophosphamide, the topoisomerase II inhibitors etoposide and pirarubicin, together with 3 months of radiotherapy, and subsequently developed Ewing sarcoma of the lower leg five years after the initial diagnosis. The cases reported in this study expand the spectrum of reported SMNs following treatment and provide pathologists with additional references for establishing pathological diagnoses on the basis of patients\u2019 medical histories and prior treatment regimens.<\/jats:p>","DOI":"10.3389\/fped.2026.1921934","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:17:01Z","timestamp":1788949021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Two cases of secondary malignant neoplasms following treatment in pediatric patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pathology, Shenzhen Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shenzhen Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shenzhen Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shenzhen Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shenzhen Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Shenzhen Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianping","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shenzhen Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/cncr.20159","article-title":"Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group","volume":"100","author":"Bisogno","year":"2004","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/03008916231160824","article-title":"Treating secondary malignant neoplasms: a burden of childhood cancer survivors","volume":"109","author":"Podda","year":"2023","journal-title":"Tumori"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/sj.bjc.6602226","article-title":"Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain","volume":"91","author":"Jenkinson","year":"2004","journal-title":"Br J Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1200\/jco.2011.34.6585","article-title":"Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"29","author":"Armstrong","year":"2011","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1182\/hematology.2022000399","article-title":"Germline risk factors for second malignant neoplasms after treatment for pediatric hematologic malignancies","volume":"2022","author":"Bhatia","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1200\/jco.2008.21.1920","article-title":"Second neoplasms in survivors of childhood cancer: findings from the childhood cancer survivor study cohort","volume":"27","author":"Meadows","year":"2009","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jfma.2021.05.012","article-title":"Characteristics and outcomes of second cancers in patients with childhood cancer: a report from the Taiwan pediatric oncology group","volume":"121","author":"Ho","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3346\/jkms.2016.31.8.1254","article-title":"Characteristics and outcomes of second malignant neoplasms after childhood cancer treatment: multi-center retrospective survey","volume":"31","author":"Koh","year":"2016","journal-title":"J Korean Med Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1158\/1078-0432.Ccr-24-0685","article-title":"Update on recommendations for surveillance for children with predisposition to hematopoietic malignancy","volume":"30","author":"Maese","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.ejca.2012.04.009","article-title":"Clear cell sarcoma of the kidney: a review","volume":"48","author":"Gooskens","year":"2012","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-0028-1086022","article-title":"Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia","volume":"220","author":"Alebouyeh","year":"2008","journal-title":"Klin Padiatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/088800101316922038","article-title":"Hodgkin\u2019s disease as a second malignant neoplasm in childhood: report of a case and review of the literature","volume":"18","author":"Ragusa","year":"2001","journal-title":"Pediatr Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1717","DOI":"10.1002\/cnr2.1717","article-title":"Acute myeloid leukemia secondary to acute B lymphoblastic leukemia treated with maintenance therapy in a child: a case report","volume":"5","author":"Wang","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.5301\/tj.5000489","article-title":"Secondary bone marrow malignancies after adjuvant chemotherapy for breast cancer: a report of 2 cases and a review of the literature","volume":"102","author":"Rossi","year":"2016","journal-title":"Tumori"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/14740338.2022.2151584","article-title":"Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects","volume":"21","author":"Di Nardo","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"B16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/15384047.2016.1139233","article-title":"How breast cancer chemotherapy increases the risk of leukemia: thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy","volume":"17","author":"Zhang","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3109\/10428194.2012.743657","article-title":"Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-hodgkin lymphoma","volume":"54","author":"Xu","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7","article-title":"Sarcoma arising in irradiated bone; report of 11 cases","volume":"1","author":"Cahan","year":"1948","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00043426-199709000-00014","article-title":"Primitive neuroectodermal tumor of bone as a second malignant neoplasm in a child previously treated for acute lymphoblastic leukemia","volume":"19","author":"Antillon","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/ajh.20012","article-title":"Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm","volume":"76","author":"Suarez","year":"2004","journal-title":"Am J Hematol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1921934\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:17:03Z","timestamp":1788949023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1921934\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":20,"alternative-id":["10.3389\/fped.2026.1921934"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1921934","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1921934"}}